Sunwin deal increases stevia capacity
This article was originally published in The Tan Sheet
Executive SummaryQufu, China-based Sunwin International Nutraceuticals acquires Qufu Shengren Pharmaceutical Co., a manufacturing facility that will be retrofitted to produce stevia, according to an April 8 announcement. The $3 million deal, made through Sunwin's subsidiary Qufu Natural Green Engineering Co., will increase the firm's stevia production capacity to 250 tons annually, said Sunwin Chairman Laiwang Zhang in the release. Sunwin's U.S. subsidiary sells stevia-based OnlySweet as a dietary supplement in the U.S
You may also be interested in...
The $9.7bn acquisition hinges on the small interfering RNA inclisiran, but an ongoing cardiovascular outcomes trial, manufacturing hurdles, and reimbursement challenges provide subjects for concern.
US congressional leaders and medtech industry advocacy group AdvaMed are giving their full-throated endorsement to a US-Mexico-Canada (USMCA) trade agreement announced by the US Trade Representative's Office on 10 December. See what AdvaMed's president and CEO, Scott Whitaker, said about it in a statement here.
FDA seems poised to approve the drug for the orphan eye disease called TED, but remains concerned about labeling for some adverse events.